Skip to main content

HIV Archives

Study finds dramatic gains in life expectancy for people with HIV in Latin America

Apr. 21, 2021—A research team from Vanderbilt University Medical Center and institutions across Latin America today reports what looks to be far the largest study to date of life expectancy for people living with HIV infection in low-income or middle-income countries.

Read more


HIV, diabetes and immune cells in fat

Mar. 18, 2021—In HIV-positive individuals with diabetes, immune cells in fat are more proinflammatory and cytotoxic and may represent a therapeutic target for diabetes.

Read more


Clinic helps prepare young HIV patients for adult care

Mar. 4, 2021—Adolescents and young adults living with HIV in Middle Tennessee are being ushered into adult care through a special transition clinic that focuses on adult skill-building and individualized therapy and discussions.

Read more


VUMC investigator expands HIV research into South Africa

Feb. 18, 2021—A Vanderbilt University Medical Center investigator is hoping to improve access to HIV testing in South Africa, where more than 7 million people are known to have the virus, by training traditional healers to perform the tests.

Read more


Key factors in HIV-1 replication

Feb. 8, 2021—HIV-1, the virus that causes AIDS, exploits inositol phosphates in T cells to aid its own assembly and maturation — suggesting that targeting inositol phosphate binding could inhibit HIV-1 replication.

Read more


HIV patients stay away after Nigerian clinic introduces fees

Dec. 10, 2020—Six years ago, in Nigeria, funding cutbacks for HIV treatment and the consequent introduction of patient fees were associated with sharp declines in new HIV clinic enrollments and patient adherence to antiretroviral therapy (ART).

Read more


Clinical trial to test HIV drugs to treat COVID-19

Oct. 16, 2020—Vanderbilt University Medical Center, in collaboration with the University of Colorado and Beth Israel Deaconess Medical Center in Boston, is leading one of the first “telemedicine” clinical trials to test a potential treatment for COVID-19.

Read more


VIGH awarded $3 million for building research capacity in Nigeria and Mozambique

Jun. 9, 2020—Vanderbilt Institute for Global Health (VIGH) has received a new research training grant and a renewal for an existing training program from the Fogarty International Center (FIC) of the National Institutes of Health (NIH) to build HIV-focused research capacity with key partners in Nigeria and Mozambique.

Read more


Pediatric HIV researcher Carlucci discusses work in Mozambique

Mar. 21, 2019—When James Carlucci, MD, MPH, instructor of Pediatric Infectious Diseases, is in Nashville he treats children at Monroe Carell Jr. Children's Hospital at Vanderbilt. When he’s on one of the several trips he takes each year to Mozambique, he’s trying to understand when and why HIV-exposed infants fall out of care — and how to change it.

Read more


New HIV research training program launched

Sep. 20, 2018—With the help of a $1.6 million grant from the National Heart, Lung and Blood Institute, Vanderbilt University Medical Center is launching a specialized research training program called Vanderbilt Scholars in HIV and Heart, Lung, Blood and Sleep Research, or V-SCHoLARs.

Read more


A “public” target for HIV

Jun. 8, 2018—Common sequences of antibodies against HIV may be key to developing a successful vaccine strategy for the virus.

Read more


HIV outreach and return to care

Nov. 9, 2017—When chronic disease patients let their care lapse and fail to show for clinic appointments, it may behoove clinics to reach out and encourage a return to care.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more